Topical phenytoin for wound healing

Dermatology Online Journal

Volumn 10, Issue 1, 2004, Pages

  Bhatia, Ashima ^a   Prakash, Surya ^b  

^a MAULANA AZAD MEDICAL COLLEGE   (India)

^b TNC Hospital   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CHLORHEXIDINE; FRAMYCETIN; HYDROGEN PEROXIDE; PHENYTOIN; SULFADIAZINE SILVER;

ABSCESS; BURN; BURNING SENSATION; CLINICAL TRIAL; DECUBITUS; DIABETIC FOOT; DRUG ABSORPTION; DRUG EFFICACY; DRUG INDICATION; DRUG MECHANISM; DRUG SAFETY; EPIDERMOLYSIS BULLOSA; HUMAN; RASH; REVIEW; WOUND DRESSING; WOUND HEALING;

EID: 6044246235     PISSN: 10872108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Kimball OP, Horan TN. The use of Dilantin in the treatment of epilepsy. Ann Intern Med 1939; 13:787-93.
2. Shapiro M. Acceleration of gingival wound healing in non-epileptic patients receiving diphenylhydantoin sodium. Exp Med Surg 1958; 16:41-53.
3. Goebil RW. Sodium diphenylhydantoin association with oral healing. J Oral Surg 1972; 30; 191-5.
4. Shafer WG, Beatty RE, Davis WB. Effect of Dilantin sodium on tensile strength of healing wounds. Proc Soc Exp Biol Med 1958; 98:348-50.
5. Kolbert GS. Oral diphenylhydantoin in corneal wound healing in the rabbit. Am J Opthamol 1968; 66:736-8.
6. Sklans S, Taylor RG, Shklar G. Effect of diphenylhydantoin sodium on healing of experimentally produced fractures in rabbit mandibles. J Oral Surg 1967; 25:310-9.
7. Gudmundson C, Lidgren L. Does diphenylhydantoin accelerate healing of fractures in mice? Acta Orthop Scand 1973; 44:640-9.
8. Frymoyer JW. Fracture healing in rats treated with diphenylhydantoin(dilantin). J Trauma 1976; 16:368-70.
9. Kuebel MA, Yeager VL, Taylor JJ.Effect of phenytoin and/or betaaminopropionitrile on surgically induced periosteal wound. J Exp Pathol 1985; 2:99-109.
10. Simpson GM, Kunz E, Slafta J. Use of diphenylhydantoin in treatment of leg ulcers. N Y State J Med 1965; 65:886-8.
11. Bansal NK, Mukul. Comparison of topical phenytoin with normal saline in the treatment of chronic trophic ulcers in leprosy. Int J Dermatol 1993; 32:210-13.
12. Malhotra YK, Amin SS. Role of topical phenytoin in trophic ulcers of leprosy in India. Int J Leprosy 1991; 59:337-8.
13. Menezes J, Rajendran A, Jacob AJW, Vaz M. The use of topical phenytoin as an adjunct to immobilization in the treatment of trophic leprosy ulcers. Southeast Asian J Trop Med Public Health 1993; 24:340-42.
14. Bogaert H, Saleta B, Sanchez E, Garcia B. Trophic leprosy ulcers: Treatment with topical and systemic phenytoin. Int J Dermatol 1990; 29:156-7.
15. El Zayat SG. Preliminary experience with topical phenytoin in wound healing in a war zone. Mil Med 1989; 28:347-50.
16. Lodha SC, Lohiya ML, Vyas MCR, Sudha Bhandari, Goyal RR, Harsh MK. Role of phenytoin in healing large abscess cavities. Br J Surg 1991; 78:105-8.
17. Muthukumarasamy MG, Sivakumar G, Manoharan G. Topical phenytoin in diabetic foot ulcers. Diabetes Care 1991; 14:909-11.
18. Pendse AK, Sharma A, Sodani A, Hada S. Topical phenytoin in wound healing. Int J Dermatol 1993; 32:214-7.
19. Oluwatosin OM, Olabanji JK, Oluwatosin OA, Tijani LA, Onyechi BA. A comparison of topical honey and phenytoin in the treatment of chronic leg ulcers. Afr J Med Med Sci 2000;29:31-4.
20. Mendiola-González JF, Espejo-Plascencia I, Chapa-Alvarez JR, Rodriguez-Noriega E. Sodium diphenylhydantoin in burns: effects on pain and healing (letter). Invest Med Int 1983; 10:449-51.
21. Yadav JK, Singhvi AM, Kumar N, Garg S. Topical phenytoin in the treatment of split-thickness skin autograft donor sites: a comparative study with polyurethane membrane drape and conventional dressing. Burns 1993; 19:306-10.
22. Rhodes RS, Heyneman CA, Culbertson VL, Wilson SE, Phatak HM. Topical phenytoin treatment of stage II decubitus ulcers in the elderly. Ann Pharmacother 2001; 35:675-81.
23. Bauer EA, Cooper TW, Tucker DR, Esterly NB. Phenytoin therapy of recessive dystrophic epidermolysis bullosa. N Engl J Med 1980; 303: 776-781.
24. Cooper TW, Bauer EA. Therapeutic efficacy of phenytoin in recessive dystrophic epidermolysis bullosa. Arch Dermatol 1984; 120:490-95.
25. Abahussein AA, al-Zayir AA, Mostafa WZ, Okoro AN. Recessive dystrophic epidermolysis bullosa treated with phenytoin. Int J Dermatol 1992; 31:730-732.
26. Caldwell-Brown D, Stern RS, Lin AN, Carter DM. Lack of efficacy of phenytoin in recessive dystrophic epidermolysis bullosa. N Engl J Med 1992; 327:163-167.
27. Masgrau-Peya E, Lacour M, Salomon D. Topical phenytoin accelerates healing in epidermolysis bullosa simplex. Dermatology 1995; 190: 254.
28. McAnally LE, Thompson D. Use of phenytoin for wound healing. Hospital Pharmacy 1992; 27:649-50.
29. Talas G, Brown RA, McGrouther A. Role of phenytoin in wound healing-a wound pharmacology perspective. Biochem Pharmacol 1999; 57:1085-94.
30. Anstead GM, Hart LM, Sunahara JF, Liter ME. Phenytoin in wound healing. Ann Pharmacol 1996; 30:768-75.
31. Shafer WG. Effect of Dilantin sodium on various cell lines in tissue culture. Proc Soc Exp Biol Med 1961; 108:694-96.
32. Vijayasingham SM, Dykes PJ, Marks R. Phenytoin has little effect on in vitro models of wound healing. Br J Dermatol 1991; 125:136-9.
33. Moy LS, Tan EML, Holness R, Uitto J. Phenytoin modulates connective tissue metabolism and cell proliferation in human skin fibroblast cultures. Arch Dermatol 1985; 121:79-83.
34. Modaghegh S, Salehian B, Tavassoli M, et al. Use of phenytoin in healing of war and non-war wounds. A pilot study of 25 cases. Int J Dermatol 1989; 28:347-350.
35. Allen LV. Phenytoin topical powder for wounds. US Pharmacist 1996; 84:86.